Lazard Asset Management LLC lessened its stake in shares of HCA Holdings, Inc. (NYSE:HCA) by 2.2% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 314,424 shares of the company’s stock after selling 7,035 shares during the period. Lazard Asset Management LLC owned 0.09% of HCA Holdings worth $27,417,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. BlackRock Inc. raised its position in shares of HCA Holdings by 2,549.4% during the 1st quarter. BlackRock Inc. now owns 20,099,811 shares of the company’s stock worth $1,788,682,000 after purchasing an additional 19,341,168 shares during the last quarter. Vanguard Group Inc. raised its position in shares of HCA Holdings by 1.9% during the 1st quarter. Vanguard Group Inc. now owns 19,576,992 shares of the company’s stock worth $1,742,157,000 after purchasing an additional 361,027 shares during the last quarter. State Street Corp raised its position in shares of HCA Holdings by 2.2% during the 1st quarter. State Street Corp now owns 13,217,212 shares of the company’s stock worth $1,176,199,000 after purchasing an additional 290,636 shares during the last quarter. Longview Partners Guernsey LTD raised its position in shares of HCA Holdings by 4.8% during the 2nd quarter. Longview Partners Guernsey LTD now owns 9,081,454 shares of the company’s stock worth $791,903,000 after purchasing an additional 414,598 shares during the last quarter. Finally, FMR LLC raised its position in shares of HCA Holdings by 15.8% during the 1st quarter. FMR LLC now owns 7,763,884 shares of the company’s stock worth $690,908,000 after purchasing an additional 1,059,925 shares during the last quarter. Hedge funds and other institutional investors own 73.75% of the company’s stock.
Shares of HCA Holdings, Inc. (NYSE HCA) opened at 77.75 on Thursday. The stock’s 50 day moving average is $78.44 and its 200-day moving average is $83.29. HCA Holdings, Inc. has a one year low of $67.00 and a one year high of $91.03. The firm has a market cap of $28.09 billion, a P/E ratio of 10.42 and a beta of 0.67.
HCA Holdings (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 25th. The company reported $1.75 earnings per share for the quarter, missing analysts’ consensus estimates of $1.80 by ($0.05). The firm had revenue of $10.73 billion during the quarter, compared to analyst estimates of $10.76 billion. HCA Holdings had a net margin of 6.64% and a negative return on equity of 48.08%. The business’s quarterly revenue was up 4.0% on a year-over-year basis. During the same period in the prior year, the firm earned $1.66 EPS. Analysts anticipate that HCA Holdings, Inc. will post $7.19 EPS for the current fiscal year.
In other news, insider Michael S. Cuffe sold 2,150 shares of the business’s stock in a transaction that occurred on Tuesday, August 15th. The shares were sold at an average price of $79.88, for a total value of $171,742.00. Following the completion of the transaction, the insider now owns 12,363 shares of the company’s stock, valued at $987,556.44. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In the last three months, insiders sold 6,450 shares of company stock valued at $529,309. Company insiders own 2.90% of the company’s stock.
Several research analysts recently weighed in on the stock. KeyCorp restated a “buy” rating and set a $95.00 price target on shares of HCA Holdings in a research report on Thursday, September 7th. ValuEngine downgraded shares of HCA Holdings from a “buy” rating to a “hold” rating in a research report on Thursday, September 7th. Cantor Fitzgerald restated a “buy” rating and set a $95.00 price target on shares of HCA Holdings in a research report on Wednesday, September 6th. Robert W. Baird reduced their price target on shares of HCA Holdings from $95.00 to $93.00 and set an “outperform” rating for the company in a research report on Tuesday, August 22nd. Finally, Morgan Stanley reduced their price target on shares of HCA Holdings from $88.00 to $85.00 and set an “equal weight” rating for the company in a research report on Thursday, August 17th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and twelve have given a buy rating to the company. HCA Holdings has an average rating of “Buy” and an average target price of $92.88.
HCA Holdings Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.